What If You Could See the Full Picture?

And Build a Roadmap and Budget in Just Days

For early- to- mid-stage biopharma companies the months-long commercialization planning process is complex and daunting, requires extensive external resources, and impedes progress towards long-term success.

Corval’s intelligent, intuitive platform provides you clarity and guidance to navigate the commercialization journey and ensure you don’t miss a single step along the path to getting your treatment to patients in need.

Case Studies

Pre-Commercial Biopharma Sought to Acquire a Late-Stage Pipeline Asset in Order to Build a Commercial Infrastructure in Support of Its First Product Launch

A pre-commercial biopharma company with a robust pipeline of rare disease assets–the majority in Phase 1 clinical trials–sought to establish a comprehensive commercialization infrastructure… READ MORE

Phase 1 Biopharma Needed to Quickly Develop and Coordinate on a Commercialization Roadmap

The Chief Executive Officer of a clinical-stage biopharmaceutical company developing a novel treatment had just hired a Chief Medical Officer, growing the company from two employees to three. The CEO, a firm believer in the importance of early commercialization planning, immediately… READ MORE

Pre-Commercial Biopharma Sought Resource Planning and Team Alignment

A pre-commercial biopharmaceutical company developing a small-molecule asset for use in oncology was in a late Phase 2 clinical trial and needed immediate assistance to build in-house expertise, accelerate critical business decisions, and set their commercialization journey… READ MORE

Questions? Let's talk

Experience Corval for Yourself

We use cookies to improve user experience and analyze website traffic. For these reasons, we may share your site usage data with our analytics partners. By using this website you consent to store on your device all the technologies described in our Privacy Policy.